DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR FLUOROURACIL

« Back to Dashboard

Clinical Trials for Fluorouracil

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00000122	Fluorouracil Filtering Surgery Study (FFSS)	Completed	National Eye Institute (NEI)	Phase 3	To determine whether postoperative subconjunctival injections of 5-fluorouracil (5-FU) increase the success rate of filtering surgery in patients at high risk for failure after standard glaucoma filtering surgery.
NCT00000758	A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women	Completed	Hoffmann-La Roche	Phase 3	To determine the efficacy and safety of intravaginal fluorouracil administered as prophylaxis in HIV-infected women who have received standard ablative therapy (surgery) for high-grade cervical dysplasia (pre-cancer of the cervix; cervical intraepithelial neoplasia). To correlate time to recurrence of cervical dysplasia with T-cell function. Women with HIV infection are at greater risk for cervical dysplasia. Because of the likelihood that untreated or recurrent cervical dysplasia may progress to invasive cancer, there is an urgent need to develop appropriate therapies.
NCT00000758	A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 3	To determine the efficacy and safety of intravaginal fluorouracil administered as prophylaxis in HIV-infected women who have received standard ablative therapy (surgery) for high-grade cervical dysplasia (pre-cancer of the cervix; cervical intraepithelial neoplasia). To correlate time to recurrence of cervical dysplasia with T-cell function. Women with HIV infection are at greater risk for cervical dysplasia. Because of the likelihood that untreated or recurrent cervical dysplasia may progress to invasive cancer, there is an urgent need to develop appropriate therapies.

Clinical Trial Conditions for Fluorouracil

Condition Name

Condition Name for Fluorouracil
Intervention	Trials
Colorectal Cancer	254
Breast Cancer	112
Gastric Cancer	84

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Fluorouracil
Intervention	Trials
Colorectal Neoplasms	421
Adenocarcinoma	170
Carcinoma	145

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Fluorouracil

Trials by Country

Trials by Country for Fluorouracil
Location	Trials
United States	4,529
Canada	301
Italy	222
Japan	184
China	178

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Fluorouracil
Location	Trials
New York	209
California	202
Illinois	180
Texas	165
Florida	157

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Fluorouracil

Clinical Trial Phase

Clinical Trial Phase for Fluorouracil
Clinical Trial Phase	Trials
Phase 4	18
Phase 3	358
Phase 2/Phase 3	40

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Fluorouracil
Clinical Trial Phase	Trials
Completed	610
Recruiting	250
Unknown status	193

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Fluorouracil

Sponsor Name

Sponsor Name for Fluorouracil
Sponsor	Trials
National Cancer Institute (NCI)	325
Sanofi	62
European Organisation for Research and Treatment of Cancer - EORTC	35

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Fluorouracil
Sponsor	Trials
Other	1555
Industry	519
NIH	334

Export unavailable in trial.
Subscribe for complete access.